WEST PHARMACEUTICAL SERVICES, INC. Interest Expense
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Interest Expense of $700.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-24.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-10-24
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for the quarter ending 2024-09-30 was $700.00K, a 75.86% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for the quarter ending 2024-03-31 was $1.60M, a 27.27% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for the quarter ending 2023-12-31 was $1.20M, a 29.41% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for the quarter ending 2023-09-30 was $2.90M, a 31.82% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for fiscal 2023 was $9.00M, a 13.92% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for fiscal 2022 was $7.90M, a 3.66% decline from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for fiscal 2021 was $8.20M, a 0.00% change from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense for fiscal 2020 was $8.20M, a 3.53% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $700.00K 10-Q · filed 2024-10-24 | $3.80M 10-Q · filed 2024-10-24 | ||||
| 2024-03-31 | $1.60M 10-Q · filed 2024-04-25 | $2.80M derived: sum of 2 quarters · filed 2024-04-25 | $5.70M derived: sum of 3 quarters · filed 2024-10-24 | $8.40M derived: sum of 4 quarters · filed 2024-10-24 | ||
| 2023-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.10M derived: sum of 2 quarters · filed 2024-10-24 | $6.80M derived: sum of 3 quarters · filed 2024-10-24 | $9.00M 10-K · filed 2024-02-20 | ||
| 2023-09-30 | $2.90M 10-Q · filed 2024-10-24 | $5.60M derived: sum of 2 quarters · filed 2024-10-24 | $7.80M 10-Q · filed 2024-10-24 | $9.50M derived: sum of 4 quarters · filed 2024-10-24 | ||
| 2023-06-30 | $2.70M 10-Q · filed 2023-07-27 | $4.90M 10-Q · filed 2023-07-27 | $6.60M derived: sum of 3 quarters · filed 2024-04-25 | $8.80M derived: sum of 4 quarters · filed 2024-04-25 | ||
| 2023-03-31 | $2.20M 10-Q · filed 2024-04-25 | $3.90M derived: sum of 2 quarters · filed 2024-04-25 | $6.10M derived: sum of 3 quarters · filed 2024-04-25 | $7.90M derived: sum of 4 quarters · filed 2024-04-25 | ||
| 2022-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.90M derived: sum of 2 quarters · filed 2024-02-20 | $5.70M derived: sum of 3 quarters · filed 2024-02-20 | $7.90M 10-K · filed 2024-02-20 | ||
| 2022-09-30 | $2.20M 10-Q · filed 2023-10-26 | $4.00M derived: sum of 2 quarters · filed 2023-10-26 | $6.20M 10-Q · filed 2023-10-26 | $8.80M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-06-30 | $1.80M 10-Q · filed 2023-07-27 | $4.00M 10-Q · filed 2023-07-27 | $6.60M derived: sum of 3 quarters · filed 2024-02-20 | $8.40M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-03-31 | $2.20M 10-Q · filed 2023-04-27 | $4.80M derived: sum of 2 quarters · filed 2024-02-20 | $6.60M derived: sum of 3 quarters · filed 2024-02-20 | $8.50M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.40M derived: sum of 2 quarters · filed 2024-02-20 | $6.30M derived: sum of 3 quarters · filed 2024-02-20 | $8.20M 10-K · filed 2024-02-20 | ||
| 2021-09-30 | $1.80M 10-Q · filed 2022-10-27 | $3.70M derived: sum of 2 quarters · filed 2022-10-27 | $5.60M 10-Q · filed 2022-10-27 | $7.70M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-06-30 | $1.90M 10-Q · filed 2022-07-28 | $3.80M 10-Q · filed 2022-07-28 | $5.90M derived: sum of 3 quarters · filed 2023-02-21 | $8.00M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-03-31 | $1.90M 10-Q · filed 2022-04-28 | $4.00M derived: sum of 2 quarters · filed 2023-02-21 | $6.10M derived: sum of 3 quarters · filed 2023-02-21 | $8.10M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2020-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.20M derived: sum of 2 quarters · filed 2023-02-21 | $6.20M derived: sum of 3 quarters · filed 2023-02-21 | $8.20M 10-K · filed 2023-02-21 | ||
| 2020-09-30 | $2.10M 10-Q · filed 2021-10-28 | $4.10M derived: sum of 2 quarters · filed 2021-10-28 | $6.10M 10-Q · filed 2021-10-28 | $8.20M derived: sum of 4 quarters · filed 2022-02-22 | ||
| 2020-06-30 | $2.00M 10-Q · filed 2021-07-30 | $4.00M 10-Q · filed 2021-07-30 | $6.10M derived: sum of 3 quarters · filed 2022-02-22 | $8.20M derived: sum of 4 quarters · filed 2022-02-22 | ||
| 2020-03-31 | $2.00M 10-Q · filed 2021-04-30 | $4.10M derived: sum of 2 quarters · filed 2022-02-22 | $6.20M derived: sum of 3 quarters · filed 2022-02-22 | $8.20M derived: sum of 4 quarters · filed 2022-02-22 | ||
| 2019-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.20M derived: sum of 2 quarters · filed 2022-02-22 | $6.20M derived: sum of 3 quarters · filed 2022-02-22 | $8.50M 10-K · filed 2022-02-22 | ||
| 2019-09-30 | $2.10M 10-Q · filed 2020-10-23 | $4.10M derived: sum of 2 quarters · filed 2020-10-23 | $6.40M 10-Q · filed 2020-10-23 | $8.70M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | $2.00M 10-Q · filed 2020-07-24 | $4.30M 10-Q · filed 2020-07-24 | $6.60M derived: sum of 3 quarters · filed 2021-02-23 | $8.60M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $2.30M 10-Q · filed 2020-04-24 | $4.60M derived: sum of 2 quarters · filed 2021-02-23 | $6.60M derived: sum of 3 quarters · filed 2021-02-23 | $8.80M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.30M derived: sum of 2 quarters · filed 2021-02-23 | $6.50M derived: sum of 3 quarters · filed 2021-02-23 | $8.40M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $2.00M 10-Q · filed 2019-10-29 | $4.20M derived: sum of 2 quarters · filed 2019-10-29 | $6.10M 10-Q · filed 2019-10-29 | $8.20M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $2.20M 10-Q · filed 2019-07-29 | $4.10M 10-Q · filed 2019-07-29 | $6.20M derived: sum of 3 quarters · filed 2020-02-24 | $7.60M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $1.90M 10-Q · filed 2019-05-08 | $4.00M derived: sum of 2 quarters · filed 2020-02-24 | $5.40M derived: sum of 3 quarters · filed 2020-02-24 | $7.60M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $3.50M derived: sum of 2 quarters · filed 2020-02-24 | $5.70M derived: sum of 3 quarters · filed 2020-02-24 | $7.80M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $1.40M 10-Q · filed 2018-10-30 | $1.30M 10-Q · filed 2017-10-31 | $3.60M derived: sum of 2 quarters · filed 2018-10-30 | $5.70M 10-Q · filed 2018-10-30 | $7.10M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $2.20M 10-Q · filed 2018-07-31 | $2.30M 10-Q · filed 2017-08-01 | $4.30M 10-Q · filed 2018-07-31 | $4.40M 10-Q · filed 2017-08-01 | $5.70M derived: sum of 3 quarters · filed 2019-02-28 | $7.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $2.10M 10-Q · filed 2018-05-08 | $3.50M derived: sum of 2 quarters · filed 2019-02-28 | $5.70M derived: sum of 3 quarters · filed 2019-02-28 | $7.70M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.60M derived: sum of 2 quarters · filed 2019-02-28 | $5.60M derived: sum of 3 quarters · filed 2019-02-28 | $8.10M 10-K · filed 2019-02-28 | ||
| 2016-09-30 | $2.20M 10-Q · filed 2017-10-31 | $4.20M derived: sum of 2 quarters · filed 2017-10-31 | $6.70M 10-Q · filed 2017-10-31 | $9.60M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-06-30 | $2.00M 10-Q · filed 2017-08-01 | $4.50M 10-Q · filed 2017-08-01 | $7.40M derived: sum of 3 quarters · filed 2018-02-26 | $11.10M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $2.50M 10-Q · filed 2017-05-05 | $5.40M derived: sum of 2 quarters · filed 2018-02-26 | $9.10M derived: sum of 3 quarters · filed 2018-02-26 | $12.50M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2015-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $6.60M derived: sum of 2 quarters · filed 2018-02-26 | $10.00M derived: sum of 3 quarters · filed 2018-02-26 | $14.10M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $3.70M 10-Q · filed 2016-10-31 | $7.10M derived: sum of 2 quarters · filed 2016-10-31 | $11.20M 10-Q · filed 2016-10-31 | $15.00M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $3.40M 10-Q · filed 2016-08-01 | $7.50M 10-Q · filed 2016-08-01 | $11.30M derived: sum of 3 quarters · filed 2017-02-28 | $15.80M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $4.10M 10-Q · filed 2016-05-06 | $7.90M derived: sum of 2 quarters · filed 2017-02-28 | $12.40M derived: sum of 3 quarters · filed 2017-02-28 | $16.60M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.30M derived: sum of 2 quarters · filed 2017-02-28 | $12.50M derived: sum of 3 quarters · filed 2017-02-28 | $16.50M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $4.50M 10-Q · filed 2015-11-02 | $8.70M derived: sum of 2 quarters · filed 2015-11-02 | $12.70M 10-Q · filed 2015-11-02 | $16.60M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $4.20M 10-Q · filed 2015-08-03 | $8.20M 10-Q · filed 2015-08-03 | $12.10M derived: sum of 3 quarters · filed 2016-02-26 | $16.50M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-03-31 | $4.00M 10-Q · filed 2015-05-06 | $7.90M derived: sum of 2 quarters · filed 2016-02-26 | $12.30M derived: sum of 3 quarters · filed 2016-02-26 | $16.40M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2013-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $8.30M derived: sum of 2 quarters · filed 2016-02-26 | $12.40M derived: sum of 3 quarters · filed 2016-02-26 | $17.00M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | $4.40M 10-Q · filed 2014-11-03 | $8.50M derived: sum of 2 quarters · filed 2014-11-03 | $13.10M 10-Q · filed 2014-11-03 | $16.60M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $4.10M 10-Q · filed 2014-08-01 | $8.70M 10-Q · filed 2014-08-01 | $12.20M derived: sum of 3 quarters · filed 2015-02-25 | $16.60M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $4.60M 10-Q · filed 2014-05-08 | $8.10M derived: sum of 2 quarters · filed 2015-02-25 | $12.50M derived: sum of 3 quarters · filed 2015-02-25 | $17.10M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2012-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $7.90M derived: sum of 2 quarters · filed 2015-02-25 | $12.50M derived: sum of 3 quarters · filed 2015-02-25 | $16.70M 10-K · filed 2015-02-25 | ||
| 2012-09-30 | $4.40M 10-Q · filed 2013-11-04 | $9.00M derived: sum of 2 quarters · filed 2013-11-04 | $13.20M 10-Q · filed 2013-11-04 | $17.70M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | $4.60M 10-Q · filed 2013-08-05 | $8.80M 10-Q · filed 2013-08-05 | $13.30M derived: sum of 3 quarters · filed 2014-02-27 | $17.80M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-03-31 | $4.30M 10-Q · filed 2013-05-06 | $8.70M derived: sum of 2 quarters · filed 2014-02-27 | $13.20M derived: sum of 3 quarters · filed 2014-02-27 | $17.80M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2011-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $8.90M derived: sum of 2 quarters · filed 2014-02-27 | $13.50M derived: sum of 3 quarters · filed 2014-02-27 | $18.20M 10-K · filed 2014-02-27 | ||
| 2011-09-30 | $4.50M 10-Q · filed 2012-11-05 | $9.10M derived: sum of 2 quarters · filed 2012-11-05 | $13.80M 10-Q · filed 2012-11-05 | $18.50M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-30 | $4.60M 10-Q · filed 2012-08-06 | $9.30M 10-Q · filed 2012-08-06 | $14.00M derived: sum of 3 quarters · filed 2013-02-27 | $18.20M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | $4.70M 10-Q · filed 2012-05-04 | $9.40M derived: sum of 2 quarters · filed 2013-02-27 | $13.60M derived: sum of 3 quarters · filed 2013-02-27 | $17.50M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $8.90M derived: sum of 2 quarters · filed 2013-02-27 | $12.80M derived: sum of 3 quarters · filed 2013-02-27 | $16.80M 10-K · filed 2013-02-27 | ||
| 2010-09-30 | $4.20M 10-Q · filed 2011-11-07 | $8.10M derived: sum of 2 quarters · filed 2011-11-07 | $12.10M 10-Q · filed 2011-11-07 | $16.20M derived: sum of 4 quarters · filed 2012-03-01 | ||
| 2010-06-30 | $3.90M 10-Q/A · filed 2011-08-08 | $7.90M 10-Q/A · filed 2011-08-08 | $12.00M derived: sum of 3 quarters · filed 2012-03-01 | $15.80M derived: sum of 4 quarters · filed 2012-03-01 | ||
| 2010-03-31 | $4.00M 10-Q · filed 2011-05-05 | $8.10M derived: sum of 2 quarters · filed 2012-03-01 | $11.90M derived: sum of 3 quarters · filed 2012-03-01 | $15.40M derived: sum of 4 quarters · filed 2012-03-01 | ||
| 2009-12-31 | $4.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $7.90M derived: sum of 2 quarters · filed 2012-03-01 | $11.40M derived: sum of 3 quarters · filed 2012-03-01 | $15.20M 10-K/A · filed 2012-03-01 | ||
| 2009-09-30 | $3.80M 10-Q · filed 2010-11-05 | $7.30M derived: sum of 2 quarters · filed 2010-11-05 | $11.10M 10-Q · filed 2010-11-05 | |||
| 2009-06-30 | $3.50M 10-Q · filed 2010-08-05 | $7.40M 10-Q · filed 2010-08-05 | ||||
| 2008-12-31 | $16.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |